Redmond Asset Management, LLC Ideaya Biosciences, Inc. Transaction History

Redmond Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$34.2 - $47.13 $1,368 - $1,885	-40 Reduced 0.31%	12,754 $559,000
Q4 2023 Feb 12, 2024	SELL	$24.59 - $35.83 $5,975 - $8,706	-243 Reduced 1.86%	12,794 $455,000
Q4 2022 Feb 06, 2023	BUY	$14.47 - $18.17 $4,876 - $6,123	337 Added 2.65%	13,037 $236,000
Q3 2022 Nov 10, 2022	SELL	$9.24 - $15.79 $184 - $315	-20 Reduced 0.16%	12,700 $189,000
Q1 2022 May 03, 2022	BUY	$11.18 - $24.02 $726 - $1,561	65 Added 0.51%	12,720 $142,000
Q4 2021 Feb 04, 2022	BUY	$20.95 - $26.88 $14,434 - $18,520	689 Added 5.76%	12,655 $299,000
Q3 2021 Oct 22, 2021	BUY	$17.26 - $27.08 $19,193 - $30,112	1,112 Added 10.25%	11,966 $305,000
Q1 2021 May 06, 2021	BUY	$13.48 - $23.77 $146,311 - $257,999	10,854 New	10,854 $255,000

206

73.6M

21.5K

20.3K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.48B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.